ReSPECT™ Clinical Trials
  • LEPTOMENINGEAL METASTASES (LM)
    • CANCER GUIDE FOR PATIENTS
      • DISEASE BACKGROUND
      • DIAGNOSIS
      • TREATMENT OPTIONS
      • RESOURCES
    • CLINICAL TRIAL
      • TRIAL INFORMATION
      • PATIENT ELIGIBILITY
      • PRINCIPAL INVESTIGATORS
      • TRIAL LOCATIONS
      • CONTACT US
      • NEXT STEPS
      • NEWS
      • PUBLICATIONS
      • RESOURCES
  • RECURRENT GLIOBLASTOMA (GBM)
    • CANCER GUIDE FOR PATIENTS
      • DISEASE BACKGROUND
      • DIAGNOSIS
      • TREATMENT OPTIONS
      • RESOURCES
    • CLINCIAL TRIAL
      • TRIAL INFORMATION
        • QUICK OVERVIEW
      • TRIAL GUIDE FOR PATIENTS
      • PATIENT ELIGIBILITY
      • PRINCIPAL INVESTIGATORS
      • TRIAL LOCATIONS
      • NEXT STEPS
      • CONTACT US
      • NEWS
      • PUBLICATIONS
      • RESOURCES
  • PEDIATRIC BRAIN CANCER
    • CANCER GUIDE FOR PATIENTS- EPENDYMOMA
      • DISEASE BACKGROUND
      • DIAGNOSIS
      • TREATMENT OPTIONS
    • CANCER GUIDE FOR PATIENTS – HIGH GRADE GLIOMA
      • DISEASE BACKGROUND
      • DIAGNOSIS
      • TREATMENT OPTIONS
    • CLINICAL TRIAL
      • TRIAL INFORMATION
      • PRINCIPAL INVESTIGATORS
      • TRIAL LOCATIONS
      • NEXT STEPS
      • NEWS
      • PUBLICATIONS
      • RESOURCES
Select Page

Targeted Radiotherapies and Brain Tumor Treatment Challenges on The Bio Report Podcast

by Plus Therapeutics | Sep 15, 2025 | Uncategorized

Marc Hedrick, M.D., President and Chief Executive Officer of Plus Therapeutics (Nasdaq: PSTV), recently joined Daniel Levine, host of The Bio Report podcast by Levine Media Group, to discuss the challenges of treating brain tumors, the limitations of current...

Plus Therapeutics CEO Highlights the Role of Precision Medicine in Cancer Treatment

by Plus Therapeutics | Sep 8, 2025 | Uncategorized

Marc Hedrick, M.D., President and CEO of Plus Therapeutics (NASDAQ: PSTV), was recently featured in Pharma’s Almanac, where he shared insights on how precision medicine is reshaping the future of oncology. Precision Medicine in Cancer Care In the article, Dr. Hedrick...

Leading Experts Discuss Leptomeningeal Metastases at SNO/ASCO CNS Metastases Conference

by Plus Therapeutics | Sep 4, 2025 | LM

Last month, several of the world’s leading experts in leptomeningeal metastases (LM) came together at the American Society of Clinical Oncology (ASCO) / Society for Neuro-Oncology (SNO) CNS Metastases Conference to share insights, research, and clinical updates on...

Highlighting Leptomeningeal Metastases at SNO/ASCO 2025

by Plus Therapeutics | Aug 20, 2025 | LM

Last week, the leadership teams of Plus Therapeutics and CNSide Diagnostics came together onsite at the SNO/ASCO 2025 CNS Metastases Conference to advance the dialogue on leptomeningeal metastases (LM). LM Symposium The jointly sponsored LM presentation and panel...

Understanding LM in Lung Cancer by Leptomeningeal Cancer Foundation

by Plus Therapeutics | Aug 19, 2025 | LM

The Leptomeningeal Cancer Foundation is hosting an important webinar on Thursday, August 21, 2025 at 11 AM PDT / 2 PM EDT, featuring two leading oncologists: Dr. Seema Nagpal – neuro-oncologist Dr. Mohana Roy – thoracic oncologist Date & Time: Thursday, August 21,...
« Older Entries
Next Entries »

Recent Posts

  • Recognizing Rare Disease Day
  • Rethinking Radiation Therapy: A Targeted Approach for Hard‑to‑Treat Cancers
  • Plus Therapeutics Announces Approval of New AMA Category III CPT® Code Supporting Use of Convection‑Enhanced Delivery with REYOBIQ™
  • Navigating the Future of Radiopharmaceuticals
  • Precision Medicine and the Next Wave of Innovation in CNS Cancers

Recent Comments

    • Expanded Access Policy
    • Privacy Policy
    • Terms of Use
    • Forward Looking Statement
    • Social Media Guidelines
    • ReSPECT Blog
    Copyright © 2026 Cerenome, Inc. All rights reserved. ReSPECT is a trademark of Cerenome, Inc. This website is intended for a U.S. audience only.
    This site uses cookies to improve your experience. A cookie is a file sent to your device when you access a site. By using this site, you agree to the use of cookies on your device for tracking and analytics. Cookie SettingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT